RecruitingNot ApplicableNCT06033183
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
Sponsor
Neolys
Enrollment
100 participants
Start Date
Dec 2, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Analysis of the individual radiosensitivity in pediatric oncology
Eligibility
Min Age: 3 YearsMax Age: 18 Years
Inclusion Criteria6
- Minor patient treated for a brain tumor, Ewing tumor, malignant mesenchymal tumor, neuroblastoma, nephroblastoma, Hodgkin's lymphoma treated with radiotherapy (+/- chemotherapy) for curative purposes.
- Children or adolescents > 3 years old and < 18 years old
- Patient with an indication for radiotherapy as part of the primary tumor local control strategy
- Theoretical indication for radiotherapy in standard fractionation (1.8 Gy to 2.2 Gy / fraction: 5 fr/week) whatever the technique and the particle used
- Patient affiliated with a social security scheme
- Patient and/or parents or holders of parental authority having dated and signed an informed consent
Exclusion Criteria8
- Patients with contraindications to blood sampling
- Patients with contraindications to radiotherapy
- Palliative radiotherapy
- Patient with previous RT treatment in the same area (re-irradiation)
- Patient with an indication of hypofractionated RT
- Patient follow-up not possible
- Persons deprived of liberty or under guardianship (including curatorship)
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALBlood sample
Blood sample collection : 2 X 5 ml
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06033183
Related Trials
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
NCT000011861 location
Response to Influenza Vaccination in Pediatric Oncology Patients
NCT053842881 location
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
NCT052943023 locations
CAYA Cancer Prospective Cohort Study
NCT076320143 locations
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
NCT051205181 location